Immunogenetic Predictors of Severe COVID-19

According to an analysis of published data, only 20% of patients with the new coronavirus infection develop severe life-threatening complications. Currently, there are no known biomarkers, the determination of which before the onset of the disease would allow assessing the likelihood of its severe c...

Full description

Bibliographic Details
Main Authors: Anna Malkova, Dmitriy Kudlay, Igor Kudryavtsev, Anna Starshinova, Piotr Yablonskiy, Yehuda Shoenfeld
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/3/211
_version_ 1797415572246364160
author Anna Malkova
Dmitriy Kudlay
Igor Kudryavtsev
Anna Starshinova
Piotr Yablonskiy
Yehuda Shoenfeld
author_facet Anna Malkova
Dmitriy Kudlay
Igor Kudryavtsev
Anna Starshinova
Piotr Yablonskiy
Yehuda Shoenfeld
author_sort Anna Malkova
collection DOAJ
description According to an analysis of published data, only 20% of patients with the new coronavirus infection develop severe life-threatening complications. Currently, there are no known biomarkers, the determination of which before the onset of the disease would allow assessing the likelihood of its severe course. The purpose of this literature review was to analyze possible genetic factors characterizing the immune response to the new coronavirus infection that could be associated with the expression of angiotension-converting enzyme 2 (ACE-2) and related proteins as predictors of severe Corona virus disease 2019 (COVID-19). We analyzed original articles published in Medline, PubMed and Scopus databases from December 2019 to November 2020. For searching articles, we used the following keywords: New coronavirus infection, Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), COVID-19, severe course, complications, thrombosis, cytokine storm, ACE-2, biomarkers. In total, 3714 publications were selected using the keywords, of which 8 were in congruence with all the criteria. The literature analysis of the association of immunogenic characteristics and the expression of ACE-2 and related proteins with the development of severe COVID-19 revealed following genetic factors: HLA-B*46:01 genotype, CXCR6 gene hypoexpression, CCR9 gene expression, TLR7, rs150892504 mutations in the ERAP2 gene, overexpression of wild-type ACE-2, TMPRSS2 and its different polymorphisms. Genes, associated with the severe course, are more common among men. According to the analysis data, it can be assumed that there are population differences. However, the diagnostic significance of the markers described must be confirmed with additional clinical studies.
first_indexed 2024-03-09T05:49:30Z
format Article
id doaj.art-ca33406d35bd4c2cb4c06cd1768b3c36
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T05:49:30Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-ca33406d35bd4c2cb4c06cd1768b3c362023-12-03T12:18:18ZengMDPI AGVaccines2076-393X2021-03-019321110.3390/vaccines9030211Immunogenetic Predictors of Severe COVID-19Anna Malkova0Dmitriy Kudlay1Igor Kudryavtsev2Anna Starshinova3Piotr Yablonskiy4Yehuda Shoenfeld5St. Petersburg State University, Saint Petersburg 199034, RussiaSechenov First Moscow State Medical University, Moscow 119435, RussiaFSBI Institute of Experimental Medicine, St. Petersburg 197376, RussiaFSBI V.A. Almazov National Medical Research Center, Ministry of Health of Russia, St. Petersburg 197241, RussiaSt. Petersburg State University, Saint Petersburg 199034, RussiaSt. Petersburg State University, Saint Petersburg 199034, RussiaAccording to an analysis of published data, only 20% of patients with the new coronavirus infection develop severe life-threatening complications. Currently, there are no known biomarkers, the determination of which before the onset of the disease would allow assessing the likelihood of its severe course. The purpose of this literature review was to analyze possible genetic factors characterizing the immune response to the new coronavirus infection that could be associated with the expression of angiotension-converting enzyme 2 (ACE-2) and related proteins as predictors of severe Corona virus disease 2019 (COVID-19). We analyzed original articles published in Medline, PubMed and Scopus databases from December 2019 to November 2020. For searching articles, we used the following keywords: New coronavirus infection, Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), COVID-19, severe course, complications, thrombosis, cytokine storm, ACE-2, biomarkers. In total, 3714 publications were selected using the keywords, of which 8 were in congruence with all the criteria. The literature analysis of the association of immunogenic characteristics and the expression of ACE-2 and related proteins with the development of severe COVID-19 revealed following genetic factors: HLA-B*46:01 genotype, CXCR6 gene hypoexpression, CCR9 gene expression, TLR7, rs150892504 mutations in the ERAP2 gene, overexpression of wild-type ACE-2, TMPRSS2 and its different polymorphisms. Genes, associated with the severe course, are more common among men. According to the analysis data, it can be assumed that there are population differences. However, the diagnostic significance of the markers described must be confirmed with additional clinical studies.https://www.mdpi.com/2076-393X/9/3/211new coronavirus infectionCOVID-19biomarkersimmunological parametersgenesHLA
spellingShingle Anna Malkova
Dmitriy Kudlay
Igor Kudryavtsev
Anna Starshinova
Piotr Yablonskiy
Yehuda Shoenfeld
Immunogenetic Predictors of Severe COVID-19
Vaccines
new coronavirus infection
COVID-19
biomarkers
immunological parameters
genes
HLA
title Immunogenetic Predictors of Severe COVID-19
title_full Immunogenetic Predictors of Severe COVID-19
title_fullStr Immunogenetic Predictors of Severe COVID-19
title_full_unstemmed Immunogenetic Predictors of Severe COVID-19
title_short Immunogenetic Predictors of Severe COVID-19
title_sort immunogenetic predictors of severe covid 19
topic new coronavirus infection
COVID-19
biomarkers
immunological parameters
genes
HLA
url https://www.mdpi.com/2076-393X/9/3/211
work_keys_str_mv AT annamalkova immunogeneticpredictorsofseverecovid19
AT dmitriykudlay immunogeneticpredictorsofseverecovid19
AT igorkudryavtsev immunogeneticpredictorsofseverecovid19
AT annastarshinova immunogeneticpredictorsofseverecovid19
AT piotryablonskiy immunogeneticpredictorsofseverecovid19
AT yehudashoenfeld immunogeneticpredictorsofseverecovid19